Tokyo:6788

Tissue Genesis LLC, and Human Life CORD Japan, Inc., Announce Exclusive Agreement to Advance Adult Stem Cell Therapies in Asia

Tissue Genesis' patented, clinical grade cell therapy processing solutions to be licensed and marketed for commercial applications and medical research in Japan and China. HOUSTON, Nov. 1, 2017 /PRNewswire/ -- Human Life CORD Japan, Inc., (HLC) a group company of Nihon Trim (Cord No. 6788, Tokyo ...

2017-11-01 10:00 2576